Phase I Trial of M7824 (MSB0011359C), a Bifunctional Fusion Protein Targeting PD-L1 and TGFβ, in Advanced Solid TumorsJulius Strauss, James L. Gulley, Liang Cao et al.|Clinical Cancer Research|2018Cited by 415
Genome-Wide Identification of PAX3-FKHR Binding Sites in Rhabdomyosarcoma Reveals Candidate Target Genes Important for Development and CancerLiang Cao, Paul S. Meltzer|Cancer Research|2010Cited by 246
Toosendanin Exerts an Anti-Cancer Effect in Glioblastoma by Inducing Estrogen Receptor β- and p53-Mediated ApoptosisLiang Cao, Jing Ma|International Journal of Molecular Sciences|2016Cited by 51
Drozitumab, a Human Antibody to Death Receptor 5, Has Potent Antitumor Activity against Rhabdomyosarcoma with the Expression of Caspase-8 Predictive of ResponseZhigang Kang, Liang Cao|Clinical Cancer Research|2011Cited by 42
<scp>BDNF</scp>‐mediated migration of cardiac microvascular endothelial cells is impaired during ageingLiang Cao, Dongqing Cai, Liang Zhang et al.|Journal of Cellular and Molecular Medicine|2012Cited by 39